RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Apr 2025)
What this means for you
Registered since 25 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88132387
- Registration number
- 5785832
- Mark type
- Slogan / phrase
- Filed
- 26 Sept 2018
- Published for opposition
- 09 Apr 2019
- Registered
- 25 Jun 2019
- Attorney of record
- Melissa Atherton
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations containing Netarsudil for the treatment of glaucoma and ocular hypertension
Owner
- ALCON INC., Fribourg, CH
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
Prior registrations
Prosecution history
- 21 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 25 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED